Borland Scott

CIK 00015270641 companyMOUNTAIN VIEW, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001527064

Recent Transactions

41 trades

Disposition from Tender
MAP Pharmaceuticals, Inc.
Common Stock
2013-03-01$25.00/sh−12,951→ 0 total
Disposition to Issuer
MAP Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2013-03-01−1,648→ 0 total
Disposition to Issuer
MAP Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2013-03-01−10,000→ 0 total
Disposition to Issuer
MAP Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2013-03-01−4,375→ 0 total
Disposition to Issuer
MAP Pharmaceuticals, Inc.
Restricted Stock Unit (RSU)
2013-03-01−3,500→ 0 total
Disposition to Issuer
MAP Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2013-03-01−2,500→ 0 total
Disposition to Issuer
MAP Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2013-03-01−13,750→ 0 total
Disposition to Issuer
MAP Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2013-03-01−35,000→ 0 total
Disposition to Issuer
MAP Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2013-03-01−1,800→ 0 total
Disposition to Issuer
MAP Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2013-03-01−3,000→ 0 total
Disposition to Issuer
MAP Pharmaceuticals, Inc.
Restricted Stock Unit (RSU)
2013-03-01−750→ 0 total
Disposition to Issuer
MAP Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2013-03-01−1,589→ 0 total
Disposition to Issuer
MAP Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2013-03-01−51,500→ 0 total
Disposition to Issuer
MAP Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2013-03-01−21,000→ 0 total
Disposition to Issuer
MAP Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2013-03-01−248→ 0 total
Disposition to Issuer
MAP Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2013-03-01−4,237→ 0 total
Disposition to Issuer
MAP Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2013-03-01−5,000→ 0 total
Disposition to Issuer
MAP Pharmaceuticals, Inc.
Restricted Stock Unit (RSU)
2013-03-01−3,375→ 0 total
Disposition to Issuer
MAP Pharmaceuticals, Inc.
Restricted Stock Unit (RSU)
2013-03-01−300→ 0 total
Disposition to Issuer
MAP Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2013-03-01−32,500→ 0 total
Disposition to Issuer
MAP Pharmaceuticals, Inc.
Restricted Stock Unit (RSU)
2013-03-01−8,250→ 0 total
Exercise/Conversion
MAP Pharmaceuticals, Inc.
Restricted Stock Unit (RSU)
2013-01-26−1,900→ 3,800 total
Exercise/Conversion
MAP Pharmaceuticals, Inc.
Common Stock
2013-01-26+1,900→ 13,058 total
Sale
MAP Pharmaceuticals, Inc.
Common Stock
2013-01-26$24.75/sh−764→ 12,294 total
Exercise/Conversion
MAP Pharmaceuticals, Inc.
Restricted Stock Unit (RSU)
2013-01-25−3,000→ 9,000 total
Exercise/Conversion
MAP Pharmaceuticals, Inc.
Common Stock
2013-01-25+3,000→ 12,475 total
Tax Payment
MAP Pharmaceuticals, Inc.
Common Stock
2013-01-25$24.75/sh−1,317→ 11,158 total
Other
MAP Pharmaceuticals, Inc.
Common Stock
2012-11-20$9.89/sh+1,158→ 9,475 total
Tax Payment
MAP Pharmaceuticals, Inc.
Common Stock
2012-06-07$12.01/sh−414→ 7,178 total
Exercise/Conversion
MAP Pharmaceuticals, Inc.
Restricted Stock Unit
2012-06-07−1,125→ 3,375 total
Exercise/Conversion
MAP Pharmaceuticals, Inc.
Common Stock
2012-06-07+1,125→ 7,592 total
Other
MAP Pharmaceuticals, Inc.
Common Stock
2012-05-20$9.81/sh+1,139→ 8,317 total
Exercise/Conversion
MAP Pharmaceuticals, Inc.
Common Stock
2012-01-26+1,900→ 7,263 total
Exercise/Conversion
MAP Pharmaceuticals, Inc.
Restricted Stock Unit (RSU)
2012-01-26−1,900→ 5,700 total
Tax Payment
MAP Pharmaceuticals, Inc.
Common Stock
2012-01-26$13.84/sh−796→ 6,467 total
Award
MAP Pharmaceuticals, Inc.
Restricted Stock Unit (RSU)
2012-01-25+12,000→ 12,000 total
Award
MAP Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2012-01-25+35,500→ 35,500 total
Other
MAP Pharmaceuticals, Inc.
Common Stock
2011-11-20$11.54/sh+896→ 5,363 total
Exercise/Conversion
MAP Pharmaceuticals, Inc.
Common Stock
2011-08-04+5,000→ 6,302 total
Tax Payment
MAP Pharmaceuticals, Inc.
Common Stock
2011-08-04$13.43/sh−1,835→ 4,467 total
Exercise/Conversion
MAP Pharmaceuticals, Inc.
Restricted Stock Unit
2011-08-04−5,000→ 3,165 total

Companies

MAP Pharmaceuticals, Inc.
SVP, Neurology Franchise

Recent Filings

4
Borland Scott
Mar 4, 2013

Address

2400 BAYSHORE PARKWAY SUITE 200

MOUNTAIN VIEW, CA, 94043

View on SEC.gov